A Biotech Founder Makes the Moral Case for Gene-Editing Human Embryos
The practice of editing the genes of embryos remains highly controversial and risky, but Origin Genomics founder Cathy Tie argues its a “moral imper...
Last updated: 2026-10-05 05:05:01 ET
The practice of editing the genes of embryos remains highly controversial and risky, but Origin Genomics founder Cathy Tie argues its a “moral imper...
In new posture, Kevin Reddington argues there was insufficient evidence that she murdered her childrenLindsay Clancy returned to court on Tuesday in h...
Netflix investors are too worried about the U.S. and are overlooking gains abroad, Deutsche Bank argues.
But the Temerario product line's director argues its V8 replacement is a bit "more rock-and-roll."
Unlock the AI Macro Analyst to drill down into the data, explore hidden risks, and query the entire market briefing in real-time.
LOG IN / SUBSCRIBE